Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 782.

@article{2019PreventionOG,
  title={Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 782.},
  author={},
  journal={Obstetrics and gynecology},
  year={2019},
  volume={134 1},
  pages={
          e19-e40
        }
}
  • Published 2019
  • Medicine
  • Obstetrics and gynecology
    • Group B streptococcus (GBS) is the leading cause of newborn infection. The primary risk factor for neonatal GBS early-onset disease (EOD) is maternal colonization of the genitourinary and gastrointestinal tracts. Approximately 50% of women who are colonized with GBS will transmit the bacteria to their newborns. Vertical transmission usually occurs during labor or after rupture of membranes. In the absence of intrapartum antibiotic prophylaxis, 1-2% of those newborns will develop GBS EOD. Other… CONTINUE READING
    View on PubMed
    journals.lww.com
    5 Citations
    5 Citations
    Citation Type

    Citation Type

    Prevention of Group B Streptococcal Early-Onset Disease in Newborns
    • 10
    • PDF
    Management of Infants at Risk for Group B Streptococcal Disease
    • 26
    • PDF
    Intrapartum beta-lactam antibiotics for preventing group B streptococcal early-onset disease: can we abandon the concept of ‘inadequate’ intrapartum antibiotic prophylaxis?
    Comparison of the Panther Fusion and BD MAX Group B Streptococcus (GBS) Assays for Detection of GBS in Prenatal Screening Specimens
    Comparison of the Panther Fusion and BD MAX GBS Assays for Detection of Group B Streptococcus in Prenatal Screening Specimens.
    • PDF

    References

    SHOWING 1-10 OF 142 REFERENCES
    Prevention of early‐onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis
    • 96
    Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
    • 170
    • PDF
    Perinatal infections due to group B streptococci.
    • 164
    Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses
    • N. Russell, A. Seale, +14 authors C. Baker
    • Medicine
    • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
    • 2017
    • 44
    • PDF
    Early-Onset Group B Streptococcal Disease in the United States: Potential for Further Reduction
    • 42
    Group B streptococcal bacteriuria during pregnancy as a risk factor for maternal intrapartum colonization: a prospective cohort study
    • 12
    Neonatal Group B Streptococcus Infections: Prevention Strategies, Clinical and Microbiologic Characteristics in 7 Years of Surveillance
    • 17
    Duration of Intrapartum Antibiotics for Group B Streptococcus on the Diagnosis of Clinical Neonatal Sepsis
    • 31
    • PDF
    Neonatal septicemia due to group B streptococci — Perinatal risk factors and outcome of subsequent pregnancies
    • 61
    • PDF
    Prevention of Perinatal Group B Streptococcal Disease
    • 437
    • PDF